🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementPancreatitis risk assessment — need advice Page 4

Pancreatitis risk assessment — need advice

nick_newbie Thu, May 30, 2024 at 12:20 AM 63 replies 3,076 viewsPage 4 of 13
julia.endo
Senior Member
1,890
9,012
Feb 2024
Cincinnati, OH
May 31, 2024 at 8:56 AM#16

From the other side of the consultation, briefly. Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then measure again under the same conditions.

Last edited: May 31, 2024 at 2:56 PM
20 18anna.melb_AU, mark_tokyo, hans_munich and 17 others
Reply Quote Save Share Report
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
May 31, 2024 at 12:21 PM#17
PeptideSynthNJ said:
One habit that pays for itself: post the method alongside the number.

There is a second half to this that has not been said yet. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

21 19Dr.DermMIA, fiona_VT, denise_HTX and 18 others
Reply Quote Save Share Report
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
May 31, 2024 at 3:45 PM#18

One concrete data point for the thread. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

22 20FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 19 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
pam_stl
Member
267
1,123
Oct 2024
St. Louis, MO
May 31, 2024 at 7:09 PM#19

Following on from PeptideSynthNJ — and this may be the naive question:

How would you tell the difference between that and the alternative explanation?

23 21SleepDoc_PDX, RegAffairsDC, BiostatsBrad and 20 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
May 31, 2024 at 10:33 PM#20

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. Tagging this one for the weekly digest.

45 18PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 42 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register